Location History:
- Bichl, DE (2011)
- Rotkruez, CH (2016)
- Rotkreuz, CH (2012 - 2020)
Company Filing History:
7 out of 622 
1 out of 832,843 Years Active: 2011-2020
Title: Hermann Leying: Innovator in Viral Detection Methods
Introduction
Hermann Leying, an accomplished inventor based in Rotkreuz, Switzerland, holds an impressive portfolio of eight patents. His work primarily focuses on the detection methods for viral pathogens, specifically Hepatitis A Virus (HAV) and Hepatitis E Virus (HEV). Leying's inventions showcase significant advancements in the field of molecular diagnostics.
Latest Patents
Leying's latest patents include groundbreaking methodologies for viral detection. One notable patent is for HAV detection, which outlines methods for identifying HAV in biological samples. This innovation involves amplifying a target nucleic acid within a reaction mixture that possibly contains the viral sequence. Additionally, the patent encompasses the development of kits designed for efficient detection of HAV.
Another significant patent addresses the HEV assay. This method allows for the simultaneous amplification of various genotypes (1, 2, 3, and/or 4) of HEV using a single, non-degenerate forward primer that partially overlaps the 5' UTR region of the virus. The patent also describes related techniques and kits aimed at the detection of these HEV genotypes.
Career Highlights
Throughout his career, Hermann Leying has made substantial contributions to the field of molecular biology and diagnostics. He has worked with esteemed organizations, including Roche Molecular Systems, Inc., where he honed his expertise in viral detection technologies. His innovative approaches have contributed significantly to advancements in medical diagnostics.
Collaborations
Leying has collaborated with notable professionals in the industry, including Dirk Zimmermann and Eberhard Russmann. These partnerships have fostered an environment of innovation and development, leading to the successful creation of his notable patents and advancements in viral detection methodologies.
Conclusion
Hermann Leying stands out as a leading inventor in the field of molecular diagnostics, particularly in the detection of Hepatitis A and E viruses. His eight patents reflect his dedication to innovation and his impact on improving viral detection methods. As the landscape of diagnostics continues to evolve, Leying's contributions will likely remain influential in shaping future developments in the field.